top of page
Need help? +33 1 76 43 14 03
How it works
A simple and intuitive solution
94% of patients find the app easy to use (Clinical study, Institut Curie, 2026).
Weekly Survey
In addition to CT scans, which are performed less frequently, the solution relies on a weekly clinical questionnaire to collect symptoms reported by the patient. The frequency of the Moovcare questionnaire enables early detection.
Algorithmic and Medical Analysis
The responses are analyzed by a dedicated algorithm and a specialized medical team composed of doctors and nurses.
Immediate notification to the oncologist
If a relevant alert is triggered, the oncologist is notified to facilitate early intervention. Contact is made only if an abnormality is detected.
A solution with proven effectiveness
Numerous clinical studies have evaluated the impact of Moovcare’s remote monitoring system on the care of cancer patients.
Clinical studies
HEALTHCARE PROFESSIONALS
Increase in life expectancy
Clinical studies have shown a 7.6-month increase in overall survival among lung cancer patients monitored with Moovcare.
(Sentinel 4 Study, Prospective Multicenter)
Reduction in hospitalizations
Une détection précoce des signaux cliniques permet d'anticiper les prises en charge et d'éviter les passages non planifiés à l'hopital.
High adherence rates
Thanks to a simple and intuitive interface, nearly all patients complete their weekly questionnaire and remain diligent in their follow-up.
A reduction in anxiety
Regular follow-ups and the medical team’s responsiveness help reduce anxiety about the wait between follow-up appointments.
Studies on lung cancer
MEDICAL TIME
A solution that optimizes clinical time
Moovcare was designed to integrate seamlessly into the daily work of oncology teams without causing organizational disruptions or wasting time.
A solution that enhances the quality of monitoring without any constraints
Moovcare ne modifie ni votre organisation ni votre parcours de soins. Il fonctionne sans outil à installer et il a aucun impact sur votre stratégie thérapeutique.
The oncologist is consulted when necessary
The Moovcare medical team handles follow-up and notifications. This enables faster response times, optimizes your clinical time, and improves care coordination.
High patient adherence
With an adherence rate of over 95%, Moovcare provides continuous monitoring between appointments and enables the collection of reliable clinical data for the oncologist.
TESTIMONIALS
What doctors say
Moovcare is a pioneering remote monitoring solution based on both rigorous clinical evaluation and extensive R&D. This finally paves the way for personalized medicine and improved patient care—something everyone has been hoping for.
Dr. Antoine Piau
E-Health Expert Physician
CHU Toulouse, France
Registering patients on Moovcare® is very quick. I explain to them that it will help us track their progress more effectively and improve their care, and they’re thrilled about it. Moovcare is definitely changing the nature of medical visits. It allows me to prepare for the visit in advance and ask patients more questions than I used to.
Dr. Xavier Zasadny
Cancérologue radiothérapeute
Polyclinique de Limoges, France
Moovcare® has been very well received by patients, thanks to its ease of use, the minimal time required to complete the questionnaires, and the sense of being in constant contact with the medical team.
Dr. Alain Livartowski
Département d'oncologie,
Institut Curie, France
scientific
Expert Committee
.webp)
Dr. Ethan Basch
Director of the UNC Lineberger Comprehensive Cancer Center and Professor at UNC-Chapel Hill
Dr. Gita Mody
Thoracic surgeon at UNC Health Care and Brigham & Women's Hospital
Dr. Alain Livartowski
Department of Oncology, Institut Curie, and the e-health project
Dr. Nicolas Girard
Head of the Thoracic Oncology Department, Institut Curie
General
Usage
Subscription
Frequently Asked Questions
Services
Ressources
+33 1 76 43 14 03
Legal Notices
Sivan Innovation
KAPSIKUM
4 rue René Razel, 91400, Saclay, France
Importer : Sivan France
163 Quai Aulagnier, 92600 Asnières-sur-Seine
Class IIa medical device.
Customized web-based remote monitoring application for lung cancer patients.
Class IIa medical device.
Web-based remote monitoring application for the early detection of toxicity associated with cancer treatments.
Medical device
These medical devices are regulated health products that bear the CE marking in accordance with these regulations.
bottom of page